Typhoid Vi polysaccharide vaccine is usually administered in children above the age of :
The core concept here is the age recommendations for typhoid vaccines. I remember that the Vi polysaccharide vaccine is typically given to older children and adults. The oral vaccine, Ty21a, is recommended for children as young as 6 years old. Wait, but the question is specifically about the Vi vaccine. Let me check the guidelines again. The CDC states that the Vi vaccine is approved for use in individuals aged 2 years and older. However, some sources might say 5 years or 6 years. Wait, maybe there's a discrepancy here. Let me confirm. The Vi polysaccharide vaccine is licensed for use in children aged 2 years and older. However, some guidelines or local recommendations might suggest starting at 6 years. Hmm, but I need to be precise. The key point is that the Vi vaccine is not recommended for children under 2 years because their immune systems may not respond adequately to the polysaccharide antigen. The live oral vaccine is preferred for younger children. So the correct answer would be children above 2 years. If the options are A. 1 year, B. 2 years, C. 5 years, D. 6 years, then the correct answer is B. But wait, sometimes the question might have different options. The user hasn't provided the options, but the correct answer is supposed to be a specific age. Let me make sure. The Vi vaccine is approved for 2 years and older. So if the options include 2 years, that's the answer. If not, maybe 5 or 6. But in standard guidelines, the Vi vaccine is for 2 years and up. Therefore, the correct answer is children above 2 years. The wrong options would be lower ages like 1 or 5, which are incorrect because the Vi vaccine isn't recommended until 2. The clinical pearl here is that for children under 2, the live oral vaccine is preferred. So the answer is B if the options include 2 years.
**Core Concept**
The Typhoid Vi polysaccharide vaccine is a T-dependent antigen that elicits a robust immune response in children aged **β₯2 years**. Younger children (<2 years) have immature T-cell responses to polysaccharide antigens, necessitating alternative vaccines like the live oral Ty21a strain.
**Why the Correct Answer is Right**
The Vi polysaccharide vaccine (e.g., Typbar-TDV) is licensed for use in **children aged 6 months and older** in some formulations but typically recommended for **children β₯2 years** in many guidelines. This is because polysaccharide vaccines require functional T-cell help for immunological memory, which develops adequately by age 2. For infants <2 years, the live attenuated oral Ty21a vaccine is preferred due to its T-independent immune response.
**Why Each Wrong Option is Incorrect**
**Option A: <2 years** β Incorrect. T-cell immaturity